Healthy Skepticism Library item: 8395

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Give us more protection, innovative drug manufacturers tell Eastman Commission
Canadian Medical Association Journal 1984 Nov 1; 131:1097-1098

Abstract:

The Pharmaceutical Manufacturers Association of Canada’s report recommending the repeal of the compulsory licensing provisions (Section 41) of the Patent Act, and the creation of a regulatory approval process that is competitive with those countries where the early investigative drug research is conducted, is discussed. The effects of granting compulsory licenses to generic manufacturers and the shortage of qualified prescription drug review personnel on research and innovation in the Canadian pharmaceutical industry are described.